Search
Synendos Therapeutics: Allschwil-based company expands financing to 24 million Swiss Francs
- ju5997
- Apr 21, 2021
- 1 min read
Ysios Capital joins the existing consortium of European investors to expand the Series A financing for Synendos Therapeutics. The Allschwil-based company will use the capital of 24 million Swiss francs to develop its innovative approach that aims to treat anxiety, mood and stress-related disorders.
Σχόλια